Selected article for: "case report and disease onset"

Author: Cosma, Laura; Sollaku, Saadi; Frantellizzi, Viviana; De Vincentis, Giuseppe
Title: Early (18)F‐FDG PET/CT in COVID‐19
  • Cord-id: a3pj22de
  • Document date: 2020_9_17
  • ID: a3pj22de
    Snippet: We report the case of who has been hospitalized complaining about fever in the last 4 days. Laboratory data revealed lymphocytopenia and leucopenia with an elevation of C‐reactive protein and positive real‐time reverse transcription‐polymerase chain reaction (RT‐PCR). Six days before this hospitalization, when the patient was asymptomatic, (18)F‐FDG PET/CT images were performed for the therapeutic control of liver metastases of colorectal cancer. Lung abnormality findings at (18)F‐FD
    Document: We report the case of who has been hospitalized complaining about fever in the last 4 days. Laboratory data revealed lymphocytopenia and leucopenia with an elevation of C‐reactive protein and positive real‐time reverse transcription‐polymerase chain reaction (RT‐PCR). Six days before this hospitalization, when the patient was asymptomatic, (18)F‐FDG PET/CT images were performed for the therapeutic control of liver metastases of colorectal cancer. Lung abnormality findings at (18)F‐FDG PET/CT images, unrelated to cancer metastases, but suspicious for viral infection, may suggest the presence of COVID‐19 disease in its early phase before symptoms onset. Since PET/CT is more sensitive than CT scan in detecting host’s reaction, the added value of this technique could be monitoring disease progression and could be used as a biomarker of lung disease activity and therefore as an important tool for a better understanding of the factors that contribute to the progression of lung disease.

    Search related documents:
    Co phrase search for related documents
    • activate inflammatory cell and lung disease progression: 1
    • acute sars respiratory syndrome coronavirus and adequate therapy: 1, 2, 3, 4, 5
    • acute sars respiratory syndrome coronavirus and liver metastasis: 1
    • acute sars respiratory syndrome coronavirus and long period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars respiratory syndrome coronavirus and lung abnormality: 1, 2
    • acute sars respiratory syndrome coronavirus and lung bone marrow: 1, 2, 3, 4, 5
    • acute sars respiratory syndrome coronavirus and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars respiratory syndrome coronavirus and lung disease progression: 1, 2, 3, 4, 5, 6, 7
    • acute sars respiratory syndrome coronavirus and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars respiratory syndrome coronavirus and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adequate therapy and lung disease: 1, 2, 3
    • adequate therapy and lymph node: 1
    • liver metastasis and lymph node: 1, 2, 3, 4
    • long period and lung disease: 1, 2
    • long period and lung involvement: 1
    • long period and lymph node: 1, 2
    • lung abnormality and lymph node: 1
    • lung bone marrow and lymph node: 1, 2, 3
    • lung bone marrow lymph node and lymph node: 1, 2, 3